Login to Your Account

Other news to note

Wednesday, December 11, 2013
Navidea Biopharmaceuticals Inc., of Dublin, Ohio, said the FDA granted fast-track designation to Lymphoseek (technetium 99m tilmanocept) injection for sentinel lymph node detection in patients with head and neck cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription